Howard Fu, CFO, sells Procore (PCOR) shares worth $55,271

Procore Technologies CFO and Treasurer Howard Fu sold 797 shares on Nov. 21, 2025 at $69.35 ($55,271) and had sold 7,203 shares on Nov. 20 at $71.74 ($516,743) to cover taxes, leaving him with 179,847 shares; the filings were reported on a Form 4. The company delivered a solid Q3 with 14.5% year-over-year revenue growth, nearly 80% gross margins and 23.3% cRPO growth, prompting multiple analysts (Stifel, Goldman Sachs, Piper Sandler, KeyBanc, Canaccord) to raise price targets into the $85–$91 range and cite margin expansion (Piper targets 14% EBIT by FY25) and an expected return to profitability this year. However, InvestingPro flags Procore as slightly overvalued and notes 15 analysts have trimmed earnings estimates, so the improving fundamentals and analyst optimism are tempered by valuation and near-term earnings uncertainty.

Analysis

Procore Technologies reported a 14.5% year-over-year revenue increase in Q3 and 23.3% cRPO growth, with gross margins near 80% and in-line fourth-quarter revenue guidance; multiple sell-side analysts (Stifel, Goldman Sachs, Piper Sandler, KeyBanc, Canaccord) raised price targets into an $85–$91 range and highlighted margin expansion and a path to profitability. CFO and Treasurer Howard Fu filed Form 4 sales on Nov. 20–21, 2025, disposing of 7,203 shares at $71.74 (tax cover) and 797 shares at $69.35 ($55,271), leaving him with 179,847 shares — sales characterized in the filing as tax-related rather than a broad insider exit. InvestingPro flags the stock as slightly overvalued and notes 15 analysts have trimmed earnings estimates recently, while consensus still expects the company to reach profitability this year and Piper Sandler projects a 14% EBIT margin by FY2025. Market-impact and sentiment signals are mildly positive (sentiment score 0.35), suggesting the market has priced in much of the favorable fundamental news but that valuation and near-term earnings revisions remain the primary risks to further upside.

Key Decisions for Investors

• Consider phased accumulation rather than a full-size entry given bullish operational momentum (Q3 beat, 23.3% cRPO) but a slightly rich valuation flagged by InvestingPro,
• Treat the CFO share sales as tax-driven and not a definitive negative signal, but monitor any follow-on non-routine insider selling as a potential red flag,
• Watch near-term EPS revision activity and the company’s progress toward profitability and Piper Sandler’s 14% EBIT margin target for FY2025; trim exposure if a sustained series of downgrades occurs,
• For shorter-term exposure, prefer position sizing discipline or hedges (e.g., protective puts or covered-call overlays) because market sentiment is only mildly positive and upside appears contingent on continued margin expansion